FDA approves new oral drug to treat multiple sclerosis - FDA Press Releases

The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

from Food and Drug Administration--Press Releases https://ift.tt/2HIkETK
via IFTTT